Company / Current Liabilities
Prime Medicine, Inc. Current Liabilities History
FY2021-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$38.0M
FY2024
5-year range
$26.7M / $58.0M
FY2021-FY2024
Trend
-32.7%
vs FY2023
Sector context
#162 of 214
Health Care
What the data says
Prime Medicine, Inc.'s current liabilities of $38M is lower than 76% of companies in the Health Care sector (FY2024). Increased from $27M to $38M over the past 2 years.
Based on SEC 10-K filings.
$38M in FY2024 with a 3-year CAGR of -13.2%.
Increased from $27M to $38M over the past 2 years.
Health Care sector context is included.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- -13.2%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 24% in Health CareTop 24% of 214This company $38.0M Sector average $1.6B
▼
-97.6% below sector average
Key checks
Key Insights
- 3-year CAGR of -13.2%, indicating a declining trend.
- In FY2024, current liabilities decreased 32.7% year-over-year.
- Ranks #162 out of 214 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -1.24 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $38.0M | -32.7% |
| FY2023 | $56.4M | +111.2% |
| FY2022 | $26.7M | -53.9% |
| FY2021 | $58.0M | - |
| FY2020 | - | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026